Yu-Tzu Tai

28PUBLICATIONS
83CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 18, 2023
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Ola Rizq, Naoya Mimura, Motohiko Oshima

|May 17, 2023
UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Ola Rizq, Naoya Mimura, Motohiko Oshima

|Feb 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

Keiji Kurata, Mehmet K Samur, Priscilla Liow

|Feb 06, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Keiji Kurata, Anna James-Bott, Mark A Tye

|Jan 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Keiji Kurata, Anna James-Bott, Mark A Tye

|Jan 11, 2023
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.

Ting Du, Yan Song, Arghya Ray

Pageof 5

Frequent Collaborators

13 joint publications

Kenneth C Anderson

7 joint publications

Mehmet Kemal Samur

4 joint publications

Nikhil Munshi

4 joint publications

Tomasz Sewastianik